About
Widely experienced multi-national pharmaceutical executive in multiple countries, with a bent in later life to life science start-ups Current & previous Board roles include: Chairman of CuroNZ, Genesis R&D, Phytomedics, Phylogica, Dentman AG and Bionik World; Director of Wool Equities, Corra Life Sciences, Encoate, Cortech, Source MDx and Biomatters, plus involvement in 18 other biotech/hi-tech startups including PhotoNZ, Cytran and Sepracor; partner, Inventages life science VC fund Previous roles include: President, Europe for Bristol-Myers Squibb; Schering AG (now Bayer Pharma) in the UK, NZ, Sweden, USA and Germany; Founding CEO of Proacta and CoDa Therapeutics
Position in the VCSift Database
- • 4 investors at BioPacific Ventures are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Aki von Roy is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like Aki
Search Investors